Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 855 of 1,261
  1. US 8519102

    Polymer Factor VIII moiety conjugates

    Nektar Therapeutics · Granted Aug 27, 2013 · Expires Aug 22, 2033

    granted
  2. US 8519158

    Androgen receptor modulator compounds and methods

    Ligand Pharmaceuticals Incorporated · Granted Aug 27, 2013 · Expires Aug 22, 2033

    granted
  3. US 8518984

    Spiro-oxindole MDM2 antagonists

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Aug 27, 2013 · Expires Aug 22, 2033

    granted
  4. US 8519103

    Factor VII polypeptides that are modified and uses thereof

    Catalyst Biosciences, Inc. · Granted Aug 27, 2013 · Expires Aug 22, 2033

    granted
  5. US 8518890

    Remedies for sex hormone dependent disease

    Takeda Pharmaceutical Company Limited · Granted Aug 27, 2013 · Expires Aug 22, 2033

    granted
  6. US 8518647

    Method of diagnosing poor survival prognosis colon cancer using miR-16b

    The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted Aug 27, 2013 · Expires Aug 22, 2033

    granted
  7. US 8518390

    Treatment of stroke and other acute neural degenerative disorders via intranasal administration of umbilical cord-derived cells

    Advanced Technologies and Regenerative Medicine, LLC · Granted Aug 27, 2013 · Expires Aug 22, 2033

    granted
  8. US 8518440

    Biodegradable osmotic pump implant for drug delivery

    Covidien LP · Granted Aug 27, 2013 · Expires Aug 22, 2033

    granted
  9. US 8518636

    Tangential flow filtration devices and methods for leukocyte enrichment

    Northwest Biotherapeutics, Inc. · Granted Aug 27, 2013 · Expires Aug 22, 2033

    granted
  10. US 8518404

    Activatable binding polypeptides and methods of identification and use thereof

    The Regents of the University of California · Granted Aug 27, 2013 · Expires Aug 22, 2033

    granted
  11. US 8518884

    Methods for treating atrial or ventricular arrhythmias by administering a G-protein alpha inhibitor

    Northwestern University · Granted Aug 27, 2013 · Expires Aug 22, 2033

    granted
  12. US 8518870

    Compositions and methods for cancer treatment using targeted carbon nanotubes

    The Board of Regents of the University of Oklahoma · Granted Aug 27, 2013 · Expires Aug 22, 2033

    granted
  13. US 8518966

    Amidoalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

    Theravance, Inc. · Granted Aug 27, 2013 · Expires Aug 22, 2033

    granted
  14. US 8518942

    Caspase inhibitors and uses thereof

    The Regents of the University of California · Granted Aug 27, 2013 · Expires Aug 22, 2033

    granted
  15. US 8518938

    c-MET protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Aug 27, 2013 · Expires Aug 22, 2033

    granted
  16. US 8518957

    Methanocarba adenosine derivatives, pharmaceutical compositions, and method of reducing intraocular pressure

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 27, 2013 · Expires Aug 22, 2033

    granted
  17. US 8518968

    Hydrazone and diacyl hydrazine compounds and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 27, 2013 · Expires Aug 22, 2033

    granted
  18. US 8518887

    Method of treating cancer with DLL4 antagonist and chemotherapeutic agent

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 27, 2013 · Expires Aug 22, 2033

    granted
  19. US 8518871

    Skin permeating and cell entering (SPACE) peptides and methods of use thereof

    The Regents of the University of California · Granted Aug 27, 2013 · Expires Aug 22, 2033

    granted
  20. US 8513390

    Modified antibody compositions, methods of making and using thereof

    CytomX Therapeutics, Inc. · Granted Aug 20, 2013 · Expires Aug 15, 2033

    granted
  21. US 8513489

    Uses of antimicrobial genes from microbial genome

    The Regents of the University of California · Granted Aug 20, 2013 · Expires Aug 15, 2033

    granted
  22. US 8513251

    Pyridazinone compounds

    Takeda Pharmaceutical Company Limited · Granted Aug 20, 2013 · Expires Aug 15, 2033

    granted
  23. US 8513252

    Pyrazole derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors

    Addex Pharma, S.A. · Granted Aug 20, 2013 · Expires Aug 15, 2033

    granted
  24. US 8513432

    Dual-acting benzoimidazole antihypertensive agents

    Theravance, Inc. · Granted Aug 20, 2013 · Expires Aug 15, 2033

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.